Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 27.0B | 26.1B | 18.2B | 15.3B |
Cost of revenue | 17.9B | 18.4B | 13.3B | 10.6B |
Gross profit | 9.0B | 7.6B | 4.9B | 4.7B |
Operating expense | ||||
Research & development | 140.3M | 169.3M | 79.4M | 20.2M |
Selling general and admin | 2.9B | 2.5B | 1.4B | 1.6B |
Other operating expenses | 983.7M | -607.1M | 437.2M | 184.4M |
Operating income | 5.4B | 3.4B | 2.4B | 2.6B |
Non operating interest income | ||||
Income | 1.2M | 2.7B | 1.2M | 1.1M |
Expense | 1.3B | 1.0B | 1.1B | 1.2B |
Other income expense | — | — | — | — |
Pretax income | 3.5B | 3.5B | 1.3B | 1.7B |
Tax provision | 879.2M | 417.9M | 743.9M | 397.1M |
Net income | 2.6B | 3.1B | 509.0M | 1.3B |
Basic EPS | 6.5 | — | 1.3 | 34.1 |
Diluted EPS | 6.5 | — | 1.3 | 34.1 |
Basic average shares | 369.3M | — | 370.5M | 36.9M |
Diluted average shares | 369.3M | — | 370.5M | 36.9M |
EBITDA | 5.3B | 5.2B | 2.8B | 3.2B |
Net income from continuing op. | 2.6B | 3.1B | 867.9M | 597.6M |
Minority interests | -165.7M | -125.9M | -38.5M | -74.1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |